UBS Leadership Transition Gains Momentum Amid Strategic and Regulatory Challenges
22.01.2026 - 07:31:08 | boerse-global.de
The process of selecting the next leader for Swiss banking giant UBS has entered a new phase. Speaking at the World Economic Forum in Davos, CEO Sergio Ermotti indicated the board of directors has broadened its search, now actively considering external candidates alongside internal executives. This development coincides with the bank's strategic reaffirmation of the United States market and its ongoing navigation of post-acquisition regulatory pressures.
During an interview in Davos, Ermotti confirmed the board has expanded its originally internal-focused succession planning process. This move to formally include external applicants sends a clear signal that the groundwork for the post-Ermotti era is being laid proactively.
Ermotti has previously stated his intention to remain in his role at least until the end of 2026, potentially extending into early 2027. This timeline is closely tied to the complex integration of Credit Suisse. The decision to widen the candidate pool suggests the board is preparing for this leadership transition well in advance.
Internal executives widely seen as leading contenders include:
- Aleksandar Ivanovic – Head of Asset Management
- Iqbal Khan – Co-Head of Global Wealth Management and President for Asia Pacific
- Robert Karofsky – Co-Head of Global Wealth Management and President for the Americas
- Beatriz Martin – Group Chief Operating Officer (as of January 1, 2026)
UBS Reaffirms Strategic Commitment to the US Market
Amid geopolitical tensions and recent US tariff threats against Europe, Ermotti used the Davos platform to underscore the enduring importance of American markets for global investors. He argued that significantly reducing exposure to the US would be a risky strategy.
“Diversifying away from America is impossible,” Ermotti stated, pointing to the continued strength of the US economy in growth and innovation. He highlighted a key statistic for a global wealth manager: approximately 25 million new millionaires were created in the US last year alone—roughly 1,000 per day. For UBS, with its deep roots in wealth management, this trend reinforces the market's strategic criticality.
Ermotti's declaration that he “would not bet against the USA” aligns directly with the firm's profit logic, positioning the region as a central growth engine for its global asset management business.
Should investors sell immediately? Or is it worth buying UBS?
Share Performance and Key Metrics
UBS shares have recently exhibited significant volatility. The stock closed yesterday in Zurich at 37.06 CHF. This represents a weekly decline of approximately 22%, though the year-to-date drop is more moderate.
A summary of notable metrics:
- 7-Day Change: -21.93%
- 30-Day Change: -6.88%
- Year-to-Date Change: -7.63%
- 52-Week High: 48.11 CHF (05.01.2026), Current Distance: -22.97%
- 52-Week Low: 26.39 CHF (19.06.2025), Current Distance: +40.43%
- 50-Day Moving Average: 39.66 CHF, Current Distance: -6.56%
- 100-Day Moving Average: 36.79 CHF
- RSI (14-Day): 63.7
- Volatility (30-Day, annualized): 110.34%
These figures place the equity well below its recent peak but still comfortably above its 52-week low. The elevated volatility reading reflects market nervousness pricing in the current mix of integration challenges, regulatory scrutiny, and management uncertainty.
Navigating Integration and Regulatory Hurdles
Operationally, UBS faces two primary challenges: the final absorption of Credit Suisse and tightening regulatory requirements in its home market.
The bank aims to complete the Credit Suisse integration by the end of 2026, a deadline that coincides with Ermotti's stated departure window. Concurrently, the firm is engaged in discussions with Swiss regulators. In a filing with the US SEC in early January, UBS noted that proposed stricter Swiss capital rules could increase its CET1 capital requirements by up to 23 billion US dollars. Such a substantial additional capital buffer could meaningfully constrain its capacity for shareholder returns via dividends or buybacks, as well as limit acquisition opportunities.
Forthcoming Milestones
The coming months will test UBS's ability to manage these parallel priorities. Two key dates are in focus:
- Early February 2026: The release of the next quarterly earnings, which should provide clarity on the operational and financial progress of the integration.
- April 2026: The Annual General Meeting, where current Group Chief Compliance Officer Markus Ronner is expected to be proposed as the new Vice-Chairman of the Board of Directors, a move intended to strengthen governance.
In summary, UBS is steering through a demanding period marked by operational and regulatory pressures on one side, and strategic leadership planning coupled with key market positioning on the other. The firm's success in harmonizing these elements will likely determine whether its share price can recover from its recent setback and move back toward its highs seen at the start of the year.
Ad
UBS Stock: Buy or Sell?! New UBS Analysis from January 22 delivers the answer:
The latest UBS figures speak for themselves: Urgent action needed for UBS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 22.
UBS: Buy or sell? Read more here...
So schätzen die Börsenprofis UBS Aktien ein!
Für. Immer. Kostenlos.
